HomeERIS • NSE
add
Eris Lifesciences Ltd
Previous close
₹1,342.60
Day range
₹1,323.00 - ₹1,396.20
Year range
₹792.35 - ₹1,399.00
Market cap
189.33B INR
Avg Volume
236.28K
P/E ratio
49.44
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 7.16B | 55.55% |
Operating expense | 3.61B | 42.79% |
Net income | 831.80M | -12.31% |
Net profit margin | 11.62 | -43.65% |
Earnings per share | 6.10 | — |
EBITDA | 2.20B | 38.94% |
Effective tax rate | 22.46% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 14.01B | 1,469.46% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 32.22B | — |
Shares outstanding | 136.14M | — |
Price to book | 7.06 | — |
Return on assets | — | — |
Return on capital | 7.25% | — |
Cash Flow
Net change in cash
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 831.80M | -12.31% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,548